Disease Overview and Diagnostic Challenges

Dr. Edwin Choy from the sarcoma oncology program and Dr. Sarah Bouberhan from gynecologic medical oncology at Massachusetts General Hospital explain that PEComas represent one subtype among 70 to 110 different sarcoma variants, derived from perivascular epithelioid cells appearing round and epithelioid under microscopy, resembling cells typically lining blood vessel walls.

PEComas are mesenchymal neoplasms that become sarcomas when malignant transformation occurs. Diagnosis requires specific immunohistochemical markers including melanocytic markers (HMB-45, Melan-A) also found in melanoma, plus smooth muscle markers (smooth muscle actin, desmin, caldesmon) typically present in regular smooth muscle. Critical diagnostic challenges arise because pathologists unfamiliar with PEComas may not consider ordering these specialized staining markers, emphasizing the importance of expert pathological review at high-volume academic medical centers with experience in rare tumor diagnosis.

PEComas demonstrate significant rarity, occurring slightly more commonly in women aged 20 to 55 years. These tumors can develop throughout the abdomen including uterus, kidney, retroperitoneum, gastrointestinal tract, liver, and lungs, making anatomical location non-specific for diagnosis. Many patients present asymptomatically with incidental discovery during routine imaging, though some experience location-dependent pain, bleeding, or mass effect symptoms.

Dr. Bouberhan emphasizes that no diagnostic radiological criteria exist for PEComas, with computed tomography and magnetic resonance imaging unable to provide definitive characteristics distinguishing these tumors from other masses. In gynecologic practice, PEComas commonly occur in the uterine corpus, overlapping radiologically with uterine fibroids despite representing radically different diagnoses. This diagnostic uncertainty reinforces the critical need for specialized pathological evaluation and heightened clinical suspicion, particularly for atypical presentations in young patients with unusual mass characteristics.

The gynecologic perspective reveals nonspecific symptomatology including pelvic pain or vaginal bleeding that fails to distinguish PEComas from other conditions without tissue diagnosis. Imaging alone cannot establish PEComa diagnosis, requiring tissue biopsy with expert pathological interpretation for accurate identification and subsequent treatment planning.